trending Market Intelligence /marketintelligence/en/news-insights/trending/KR95OfVSeDi6nkB9uyd_Xw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

S&P cuts Owens & Minor's corporate credit rating

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

S&P cuts Owens & Minor's corporate credit rating

S&P Global Ratings downgraded Owens & Minor Inc.'s corporate credit and issue-level ratings to BBB- from BBB and removed the ratings from CreditWatch, where they were placed with negative implications.

The outlook on the ratings is stable.

The rating cut comes following the Byram Healthcare deal, which S&P believes provides modest improvements to the company's scale, competitive position, EBITDA margins and growth profile through expanded capabilities to support the post-acute direct-to-consumer healthcare market, but these factors are more than offset by the material increase in debt leverage and exposure to Medicare reimbursement.

S&P said the stable outlook reflects its view that the company can achieve modest organic revenue growth, with stable-to-improving margins; generate good free cash flow; continue to pursue a moderate level of acquisitions; and maintain adjusted debt leverage of 2.5x to 3x over the next two years.

S&P Global Ratings and S&P Global Market Intelligence are owned by S&P Global Inc.